A randomized double-blind placebo-controlled phase IIB trial of curcumin in oral leukoplakia MA Kuriakose, K Ramdas, B Dey, S Iyer, G Rajan, KK Elango, A Suresh, ... Cancer Prevention Research 9 (8), 683-691, 2016 | 85 | 2016 |
Methacrylic-based nanogels for the pH-sensitive delivery of 5-fluorouracil in the colon N Ashwanikumar, NA Kumar, SA Nair, GSV Kumar International journal of nanomedicine, 5769-5779, 2012 | 60 | 2012 |
Dual drug delivery of 5-fluorouracil (5-FU) and methotrexate (MTX) through random copolymeric nanomicelles of PLGA and polyethylenimine demonstrating enhanced cell uptake and … N Ashwanikumar, NA Kumar, SA Nair, GSV Kumar Colloids and surfaces B: Biointerfaces 122, 520-528, 2014 | 58 | 2014 |
Self-assembling peptide nanofibers containing phenylalanine for the controlled release of 5-fluorouracil N Ashwanikumar, NA Kumar, PS Saneesh Babu, KC Sivakumar, ... International journal of nanomedicine, 5583-5594, 2016 | 30 | 2016 |
5-Fluorouracil–lipid conjugate: Potential candidate for drug delivery through encapsulation in hydrophobic polyester-based nanoparticles N Ashwanikumar, NA Kumar, SA Nair, GSV Kumar Acta biomaterialia 10 (11), 4685-4694, 2014 | 28 | 2014 |
Phenylalanine-containing self-assembling peptide nanofibrous hydrogel for the controlled release of 5-fluorouracil and leucovorin N Ashwanikumar, NA Kumar, SA Nair, GSV Kumar RSC Advances 4 (55), 29157-29164, 2014 | 16 | 2014 |
Complement-mediated neutralization of a potent neurotropic human pathogen, Chandipura virus, is dependent on C1q U Kunnakkadan, J Nag, NA Kumar, RK Mukesh, SM Suma, JB Johnson Journal of Virology 93 (19), 10.1128/jvi. 00994-19, 2019 | 12 | 2019 |
In the crosshairs: RNA viruses or complement? NA Kumar, U Kunnakkadan, S Thomas, JB Johnson Frontiers in Immunology 11, 573583, 2020 | 11 | 2020 |
Selective Translocation of Cyclic Sugars through Dynamic Bacterial Transporter D Vikraman, R Satheesan, M Rajendran, NA Kumar, JB Johnson, ... ACS sensors 7 (6), 1766-1776, 2022 | 10 | 2022 |
A factor I-like activity associated with chikungunya virus contributes to its resistance to the human complement system J Nag, RK Mukesh, SM Suma, U Kunnakkadan, NA Kumar, JB Johnson Journal of Virology 94 (7), 10.1128/jvi. 02062-19, 2020 | 10 | 2020 |
Poly (D, L-lactic-co-glycolide) nanoparticles for the improved therapeutic efficacy of all-trans-retinoic acid: a study of acute myeloid leukemia (AML) cell differentiation in … A Mary Simon, S Jagadeeshan, E Abraham, A Akhilandeshwaran, ... Medicinal chemistry 8 (5), 805-810, 2012 | 9 | 2012 |
Chandipura virus induces cell death in cancer cell lines of human origin and promotes tumor regression in vivo RK Mukesh, AA Kalam, J Nag, VS Jaikumar, U Kunnakkadan, NA Kumar, ... Molecular Therapy-Oncolytics 23, 254-265, 2021 | 2 | 2021 |
Functional Dissection of the Dominant Role of CD55 in Protecting Vesicular Stomatitis Virus against Complement-Mediated Neutralization * Nisha Asok Kumar 1,2, Sreenath Muraleedharan Suma 1 , Umerali Kunnakkadan ... Viruses 13 (3), 373, 2021 | 1 | 2021 |
Virome: Sentinels or Marauders in the Microbiome J Nag, NA Kumar, RK Mukesh, U Kunnakkadan, JB Johnson Human Microbiome: Clinical Implications and Therapeutic Interventions, 215-240, 2022 | | 2022 |
Potential role of vesicular stomatitis virus signatures in complement activation and modulation NA Kumar, JB Johnson Molecular Immunology 102, 132, 2018 | | 2018 |
Recruitment of CD46 and CD55 by Vesicular Stomatitis Virus is a specific modulatory function adopted by the virus to evade complement mediated neutralization NA Kumar, DS Lyles, JB Johnson Immunobiology 10 (221), 1216, 2016 | | 2016 |
Molecular Dissection and Functional Elucidation of the Interaction of Rhabdoviral Signatures with Complement Proteins NA Kumar Manipal, 0 | | |